Jump to navigation
The latest clinical and political news for Australian Rheumatologists
Professor Buchbinder throws down the gauntlet
Many patients go undiagnised for years.
ARA2018 delegates told few patients referred for exercise therapy.
International expert speaks to ARA2018 delegates
Specialists from other fields to present.
The safety profile is similar to IV administration.
'Another reason for patients to take off a few pounds'
GPs are more likely to offer medication than to refer, BEACH data shows.
It is the disease's 'most devasting' extra-articular manifestation
This goal is achievable in most children thanks to therapeutic advances, the experts say.
It's important to encourage these patients to quit smoking, researchers say.
Results from a large UK study.
But some say the data is insufficient to rule out a benefit in acute cases.
A trial shows patients had improved symptoms and reduced analgesia.
The development of highly specific antibodies known as biologics requires a mix of inspiration and good fortune
Differences in the oral microbiome in Sjögren’s may be due to lack of saliva.
It is inefficacious for a third of patients: study
But there's five pathological causes to watch for, experts say.
The interleukin-17A inhibitor also benefited the joints.
In the first year the effects differ depending on the agent.
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.